| Literature DB >> 35096014 |
Huijie Sun1, Xinghua Cai1, Bing Yan2, Huashan Bai1, Duotao Meng1, Xueyan Mo1, Sheng He3, Guijiao Su1, Chengjian Jiang1,2.
Abstract
Investigating microbial lipid regulation contributes to understanding the lipid-dependent signal transduction process of cells and helps to improve the sensitivity of microorganisms to environmental factors by interfering with lipid metabolism, thus beneficial for constructing advanced cell factories of novel molecular drugs. Integrated omics technology was used to systematically reveal the lipid metabolism mechanism of a marine Meyerozyma guilliermondii GXDK6 under high NaCl stress and test the sensitivity of GXDK6 to antibiotics when its lipid metabolism transformed. The omics data showed that when GXDK6 perceived 10% NaCl stress, the expression of AYR1 and NADPH-dependent 1-acyldihydroxyacetone phosphate reductase was inhibited, which weaken the budding and proliferation of cell membranes. This finding was further validated by decreased 64.39% of OD600 under 10% NaCl stress when compared with salt-free stress. In addition, salt stress promoted a large intracellular accumulation of glycerol, which was also verified by exogenous addition of glycerol. Moreover, NaCl stress remarkably inhibited the expression of drug target proteins (such as lanosterol 14-alpha demethylase), thereby increasing sensitivity to fluconazole. This study provided new insights into the molecular mechanism involved in the regulation of lipid metabolism in Meyerozyma guilliermondii strain and contributed to developing new methods to improve the effectiveness of killing fungi with lower antibiotics.Entities:
Keywords: Meyerozyma guilliermondii; antibiotics; integrated omics technology; lipid metabolism; signal transduction
Year: 2022 PMID: 35096014 PMCID: PMC8792971 DOI: 10.3389/fgene.2021.798535
Source DB: PubMed Journal: Front Genet ISSN: 1664-8021 Impact factor: 4.599
FIGURE 1Growth of GXDK6 under NaCl stress. (A) Growth curve of GXDK6 under different NaCl stresses; (B) morphology of GXDK6 under 0% NaCl; (C) morphology of GXDK6 under 10% NaCl; (D) Gene enrichment analysis of lipid metabolism.
KEGG pathway enrichment analysis of lipid metabolism in GXDK6.
| Pathway | Number of genes |
|---|---|
| Fatty acid biosynthesis | 11 |
| Fatty acid elongation | 9 |
| Fatty acid degradation | 19 |
| Synthesis and degradation of ketone bodies | 2 |
| Cutin, suberine and wax biosynthesis | 1 |
| Steroid biosynthesis | 15 |
| Primary bile acid biosynthesis | 1 |
| Secondary bile acid biosynthesis | 1 |
| Steroid hormone biosynthesis | 4 |
| Glycerolipid metabolism | 24 |
| Glycerophospholipid metabolism | 30 |
| Ether lipid metabolism | 5 |
| Arachidonic acid metabolism | 4 |
| Linoleic acid metabolism | 1 |
| alpha-Linolenic acid metabolism | 5 |
| Sphingolipid metabolism | 14 |
| Lipid biosynthesis proteins | 26 |
| Biosynthesis of unsaturated fatty acids | 13 |
FIGURE 2Transcriptome analysis of lipid metabolism. (A) Expression of differentially expressed genes at 0, 5, and 10% NaCl; (B) Enrichment of pathways under different NaCl stress; (C) Heatmap of differentially expressed genes.
FIGURE 3Proteomic analysis of lipid metabolism. (A) Number of differentially expressed proteins under different salt stress; (B) Pathway enrichment of differentially expressed proteins; (C) Differentially expressed proteins under different salt stress.
FIGURE 4Association analysis of multi-omics data relevant to lipid metabolism. (A) Multi-omics association analysis under the condition of 0%-vs-5%; (B) Multi-omics association analysis under the condition of 0%-vs-10%; (C) Multi-omics association analysis under the condition of 5%-vs-10%; (D) KO enrichment of related differentially expressed genes and differentially expressed proteins; (E) Related differentially expressed genes and differentially expressed proteins.
FIGURE 5Drug resistance of GXDK6 to fluconazole under NaCl stress.
Drug resistance of GXDK6 to fluconazole under NaCl stress.
| Conditions | Dilution times | Cfu/ml |
|---|---|---|
| 0%NaCl+0 μg/ml fluconazole | 10–6 | 2.1*108 |
| 5%NaCl+0 μg/ml fluconazole | 10–6 | 1.0*107 |
| 10%NaCl+0 μg/ml fluconazole | 10–5 | 9.0*105 |
| 0%NaCl+64 μg/ml fluconazole | 10–5 | 1.0*106 |
| 5%NaCl+64 μg/ml fluconazole | 10–3 | 1.1*105 |
| 10%NaCl+64 μg/ml fluconazole | 10–2 | 2.3*104 |